Amylyx Pharmaceuticals to Participate in the SVB Securities Global Biopharma Conference

Rhea-AI Summary

Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) announced that Co-CEOs Joshua Cohen and Justin Klee will participate in the SVB Securities Global Biopharma Conference on February 14, 2023, at 10:00am ET. The conference will be held virtually, and a live webcast of their presentation will be available in the 'Events' section of the company's website. A replay will be accessible for 90 days post-event. Amylyx is focused on developing innovative treatments for neurodegenerative diseases, with operations based in Cambridge, Massachusetts, and across Canada and EMEA.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX), today announced that Joshua Cohen and Justin Klee, Co-CEOs of Amylyx, will participate in the SVB Securities Global Biopharma Conference. The conference is being conducted in a virtual format, and the fireside chat will take place on Tuesday, February 14, 2023, at 10:00am ET.

A live webcast of the presentation can be accessed under “Events” in the Investor section of the Company’s website, https://investors.amylyx.com/news-events/events, and will be available for replay for 90 days following the event.

About Amylyx Pharmaceuticals

Amylyx Pharmaceuticals, Inc. is committed to supporting and creating more moments for the neurodegenerative disease community through the discovery and development of innovative new treatments. Amylyx is headquartered in Cambridge, Massachusetts and has operations in Canada and EMEA. For more information, visit amylyx.com and follow us on LinkedIn and Twitter. For investors, please visit investors.amylyx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230207005048/en/

Media

Amylyx Media Team

+1 (857) 799-7274

amylyxmediateam@amylyx.com



Investors

Lindsey Allen

Amylyx Pharmaceuticals, Inc.

+1 (857) 320-6244

Investors@amylyx.com

Source: Amylyx Pharmaceuticals, Inc.

FAQ

What is the date and time of the SVB Securities Global Biopharma Conference for AMLX?

The SVB Securities Global Biopharma Conference for Amylyx Pharmaceuticals (AMLX) is scheduled for February 14, 2023, at 10:00am ET.

How can I access the AMLX presentation at the biopharma conference?

You can access the live webcast of the AMLX presentation under the 'Events' section on the company's website.

Will the AMLX conference presentation be available after the event?

Yes, the presentation will be available for replay for 90 days following the event.

Where is Amylyx Pharmaceuticals located?

Amylyx Pharmaceuticals is headquartered in Cambridge, Massachusetts.

What is the focus of Amylyx Pharmaceuticals?

Amylyx Pharmaceuticals is committed to developing innovative treatments for the neurodegenerative disease community.